<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00334711</url>
  </required_header>
  <id_info>
    <org_study_id>2003/10/196</org_study_id>
    <secondary_id>97/29/AH/mbs NTNU</secondary_id>
    <secondary_id>Jnr 207/mkd NTNU</secondary_id>
    <secondary_id>CCPPRB Necker GLIDKIR6.2</secondary_id>
    <nct_id>NCT00334711</nct_id>
  </id_info>
  <brief_title>Sulfonylurea Response in Patients With Diabetes Due to Kir6.2 Mutations</brief_title>
  <official_title>A Prospective Study of Sulfonylureas in Patients With Diabetes Due to Kir6.2 Mutations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Royal Devon and Exeter NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Wellcome Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hôpital Necker-Enfants Malades</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Haukeland University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Royal Devon and Exeter NHS Foundation Trust</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate whether patients with diabetes due to Kir6.2
      mutations can be treated with sulfonylurea medication rather than insulin, and if this is the
      case to investigate the mechanism for sulfonylurea response.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2004</start_date>
  <completion_date>January 2006</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>HbA1c reduction</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>insulin secretory response to intravenous glucose</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>insulin secretory response to oral glucose</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>insulin secretory response to mixed meal (sustacal)</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Hypoglycemia</measure>
  </secondary_outcome>
  <enrollment>50</enrollment>
  <condition>Diabetes Mellitus</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sulfonylurea</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diabetes due to KCNJ11 (Kir6.2) mutation

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrew T Hattersley</last_name>
    <role>Study Director</role>
    <affiliation>Peninsula Medical School, Exeter, UK</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ewan R Pearson</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peninsula Medical School, Exeter, UK</affiliation>
  </overall_official>
  <link>
    <url>http://www.diabetesgenes.org</url>
  </link>
  <reference>
    <citation>Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, Howard N, Srinivasan S, Silva JM, Molnes J, Edghill EL, Frayling TM, Temple IK, Mackay D, Shield JP, Sumnik Z, van Rhijn A, Wales JK, Clark P, Gorman S, Aisenberg J, Ellard S, Njølstad PR, Ashcroft FM, Hattersley AT. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med. 2004 Apr 29;350(18):1838-49. Erratum in: N Engl J Med. 2004 Sep 30;351(14):1470.</citation>
    <PMID>15115830</PMID>
  </reference>
  <results_reference>
    <citation>Pearson ER, Flechtner I, Njølstad PR, Malecki MT, Flanagan SE, Larkin B, Ashcroft FM, Klimes I, Codner E, Iotova V, Slingerland AS, Shield J, Robert JJ, Holst JJ, Clark PM, Ellard S, Søvik O, Polak M, Hattersley AT; Neonatal Diabetes International Collaborative Group. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med. 2006 Aug 3;355(5):467-77.</citation>
    <PMID>16885550</PMID>
  </results_reference>
  <verification_date>June 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 7, 2006</study_first_submitted>
  <study_first_submitted_qc>June 7, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 8, 2006</study_first_posted>
  <last_update_submitted>November 28, 2006</last_update_submitted>
  <last_update_submitted_qc>November 28, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 29, 2006</last_update_posted>
  <keyword>Permanent Neonatal Diabetes</keyword>
  <keyword>Kir6.2</keyword>
  <keyword>KCNJ11</keyword>
  <keyword>Infancy onset diabetes</keyword>
  <keyword>Sulfonylurea</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

